---
figid: PMC4511315__tca0006-0390-f1
figtitle: Schematic diagram for signaling regulation of acetylcholinesterase (AChE)
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Gallus gallus
- Nicotiana tabacum
- Human gammaherpesvirus 8
pmcid: PMC4511315
filename: tca0006-0390-f1.jpg
figlink: /pmc/articles/PMC4511315/figure/fig01/
number: F1
caption: Schematic diagram for signaling regulation of acetylcholinesterase (AChE).
  AChE may bind laminin-1 contributing to cell-to-cell recognition. During the early
  phase of apoptosis, AChE may translocate into the nucleus, and then shuttle to the
  cytoplasm. In the nucleus, AChE may interact with nuclear proteins, for example,
  transcriptional co-repressor C-terminal binding protein (CtBP), while in the cytoplasm,
  AChE may bind to caveolin-1, assisting the interaction of apoptotic protease-activating
  factor-1 (Apaf-1) and cytochrome C (Cyt C), promoting apoptosis. Anticancer drugs,
  such as thapsigargin and cisplatin, ZD55-AChE (overexpressed AChE by oncolytic adenoviral
  vector), could upregulate the expression of AChE, and may promote apoptosis through
  the c-Jun N-terminal kinase (JNK) pathway, inhibiting phosphatidylinositol-3 kinase
  (PI3K)/protein kinase B (Akt) and mitogen activated protein kinase (MAPK) signaling
  pathways while activating glycogen synthase kinase (GSK)-3β, which may suppress
  cell proliferation. High cytoplasm calcium concentration also upregulated AChE expression,
  while the intracellular Ca2+ chelator, BAPTA-AM, decreased the AChE level. (a) AChE
  involved in transforming growth factor (TGF)-β1-induced epithelial-mesenchymal transition
  (EMT). (b) AChE may associate with anti-angiogenesis. EGF, epidermal growth factor;
  FGF2, fibroblast growth factor 2; mAchR, muscarinic acetylcholine receptor; nAchR,
  nicotinic acetylcholine receptor; SP600125, specific inhibitor of stress activated
  kinases (SAPK)/JNK; TNF-α, tumor necrosis factor α; VEGF, vascular endothelial growth
  factor.
papertitle: Role of acetylcholinesterase in lung cancer.
reftext: Hui-Jun Xi, et al. Thorac Cancer. 2015 Jul;6(4):390-398.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9353141
figid_alias: PMC4511315__F1
figtype: Figure
organisms_ner:
- Rattus norvegicus
- Gallus gallus
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC4511315__F1
ndex: 3b06b88c-df08-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4511315__tca0006-0390-f1.html
  '@type': Dataset
  description: Schematic diagram for signaling regulation of acetylcholinesterase
    (AChE). AChE may bind laminin-1 contributing to cell-to-cell recognition. During
    the early phase of apoptosis, AChE may translocate into the nucleus, and then
    shuttle to the cytoplasm. In the nucleus, AChE may interact with nuclear proteins,
    for example, transcriptional co-repressor C-terminal binding protein (CtBP), while
    in the cytoplasm, AChE may bind to caveolin-1, assisting the interaction of apoptotic
    protease-activating factor-1 (Apaf-1) and cytochrome C (Cyt C), promoting apoptosis.
    Anticancer drugs, such as thapsigargin and cisplatin, ZD55-AChE (overexpressed
    AChE by oncolytic adenoviral vector), could upregulate the expression of AChE,
    and may promote apoptosis through the c-Jun N-terminal kinase (JNK) pathway, inhibiting
    phosphatidylinositol-3 kinase (PI3K)/protein kinase B (Akt) and mitogen activated
    protein kinase (MAPK) signaling pathways while activating glycogen synthase kinase
    (GSK)-3β, which may suppress cell proliferation. High cytoplasm calcium concentration
    also upregulated AChE expression, while the intracellular Ca2+ chelator, BAPTA-AM,
    decreased the AChE level. (a) AChE involved in transforming growth factor (TGF)-β1-induced
    epithelial-mesenchymal transition (EMT). (b) AChE may associate with anti-angiogenesis.
    EGF, epidermal growth factor; FGF2, fibroblast growth factor 2; mAchR, muscarinic
    acetylcholine receptor; nAchR, nicotinic acetylcholine receptor; SP600125, specific
    inhibitor of stress activated kinases (SAPK)/JNK; TNF-α, tumor necrosis factor
    α; VEGF, vascular endothelial growth factor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ache
  - Vegfa
  - Egf
  - Fgf2
  - Slc22a3
  - Tnf
  - Chrnb1
  - Chrne
  - Mir212
  - Pik3cg
  - Apaf1
  - Akt1
  - Mapk8
  - ACHE
  - VEGFA
  - EGF
  - FGF2
  - LITAF
  - ITGB3
  - CHRNB3
  - CAV1
  - MIR212
  - APAF1
  - FGFR3
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - FGF13
  - ITK
  - SLC22A3
  - TNF
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - TGFA
  - TNFRSF1A
  - TNFRSF1B
  - TNFRSF10A
  - TNFRSF10B
  - TNFRSF10C
  - TNFRSF10D
  - FAS
  - CHRNA4
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - CIB1
  - Itk
  - Chrna7
  - Pik3r1
  - Casp9
  - Hbb-bt
  - BAPTA
  - Nicotine
  - Physostigmine
  - Thapsigargin
---
